+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GANESHBE

Ganesh Benzoplast Share Price

 

 

Ganesh Benzoplast live price: ₹108.28. It opened at ₹109 vs previous close ₹108; intraday high/low: ₹113/₹108. The 50 & 200 DMA stand at ₹96.45/₹92.32.

Ganesh Benzoplast Performance

  • Today's Low
  • ₹108
  • Today's High
  • ₹113
  • 52 Week Low
  • ₹68
  • 52 Week High
  • ₹118
  • Open Price₹109
  • Previous Close₹108
  • Volume284,707
  • 50 DMA₹96.45
  • 100 DMA₹91.68
  • 200 DMA₹92.32

Ganesh Benzoplast Chart

Investment Returns

  • Over 1 Month + 20.67%
  • Over 3 Month + 38.5%
  • Over 6 Month + 36.67%
  • Over 1 Year + 0.31%

Smart Investing Starts Here Start SIP with Ganesh Benzoplast for Steady Growth!

Invest Now

Ganesh Benzoplast Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 10.6
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 780
  • P/B Ratio
  • 1.3
  • Average True Range
  • 5.77
  • EPS
  • 9.28
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.69
  • RSI
  • 60.65
  • MFI
  • 67.77

Ganesh Benzoplast Financials

Ganesh Benzoplast Technicals

EMA & SMA

Current Price
₹108.28
+ 0.05 (0.05%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹102.10
  • 50 Day
  • ₹96.40
  • 100 Day
  • ₹91.70
  • 200 Day
  • ₹92.30

Resistance and Support

109.73 Pivot Speed
  • R3 116.64
  • R2 114.82
  • R1 111.55
  • S1 106.46
  • S2 104.64
  • S3 101.37

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ganesh Benzoplast Ltd. manufactures and supplies specialty chemicals and food preservatives, including benzoic acid and sodium benzoate. It also offers liquid storage terminal services, serving industries like food, pharmaceuticals, and petrochemicals across domestic and international markets.

Ganesh Benzoplast has an operating revenue of Rs. 411.42 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 24% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 24% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 43 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ganesh Benzoplast Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-27 Audited Results
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results & A.G.M.
2025-05-14 Audited Results

Ganesh Benzoplast Shareholding Pattern

39.02%
0.73%
0%
47.68%
12.57%

Ganesh Benzoplast FAQs

Ganesh Benzoplast share price is ₹108 As on 14 June, 2026 | 04:46

The Market Cap of Ganesh Benzoplast is ₹779.5 Cr As on 14 June, 2026 | 04:46

The P/E ratio of Ganesh Benzoplast is 10.6 As on 14 June, 2026 | 04:46

The PB ratio of Ganesh Benzoplast is 1.3 As on 14 June, 2026 | 04:46

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23